TMCnet News
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Towers Watson & Co.Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Towers Watson & Co. ("TW" or the "Company") (NASDAQ: TW), concerning the Company's proposed acquisition by Willis Group Holdings PLC. Under the terms of the proposal, TW shareholders will receive 2.6490 Willis shares for each TW share common stock they own, in addition to $4.87 in cash. The total deal consideration per share would be approximately $125.13 per share of TW. At least one analyst has set a high target price of $157.00 for TW shares. The entire transaction is valued at approximately $18 billion. The investigation is focused on whether TW's Board of Directors breached its fiduciary duty in failing to maximize consideration to shareholders, the potential unfairness of the consideration to shareholders, the process by which the Board of Director considered the transaction, and potential conflicts of interest among TW's Board of Directors' members. If you are interested in discussing your rights as a TW shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or (202) 337-8000, or by email at [email protected]. Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers. To learn more about Finkelstein Thompson LLP, please visit our website at www.finkelsteinthompson.com. Attorney advertising. Prior results do not guarantee similar outcomes. View source version on businesswire.com: http://www.businesswire.com/news/home/20150630006580/en/ |
